Sign up
Quantellect · Congress · Issuer Profile
NASDAQ: NEONeoGenomics Inc
HealthcareMkt Cap $2.25BCongress ownership rank #1839

NeoGenomics Inc Congressional Trading

According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 7 trades in NeoGenomics Inc (NASDAQ: NEO) since 2019, across 4 members, worth an estimated $72.50K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). 5 buys against 2 sells, a modestly buy-led skew, with Democratic members responsible for 71% of the trades and Republican members 29%. One notable disclosed move was a purchase by Gilbert Cisneros on August 7, 2026, down 7.7% since. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. NeoGenomics Inc's current Quantellect Tide Score is 45 out of 100 (Calm Tide), Bottom 35% of universe (3865); the Tide Score is generated algorithmically from public filings and market data and is not investment advice. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the NeoGenomics Inc (NEO) stock overview and the complete trade table below.

Data updated

Trades
1
Politicians
1
Filings
1
Disclosed Vol
$8.00K
Buys
1
100%
Sells
0
0%

Price & congressional trade timeline

Party breakdown

NeoGenomics congressional trading activity

PoliticianPublishedTradedFiled AfterTypeSizeReturnOwner
Sep 10, 2026Aug 7, 202634 daysBuy
$1,001 - $15,000
-7.72%Self
Go to

NeoGenomics (NEO) congressional trading FAQ

Can members of Congress legally trade NeoGenomics (NEO) stock?

Yes. Members of Congress are permitted to trade individual stocks, including NeoGenomics (NEO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; it does not imply any trade was improper.

Are congressional NeoGenomics (NEO) trades public?

Yes. Every congressional trade in NeoGenomics (NEO) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.

How many times has Congress traded NeoGenomics (NEO)?

Members of Congress have disclosed 7 trades in NeoGenomics (NEO) worth $72.50K across 4 members, according to public STOCK Act filings.

Which members of Congress have traded NeoGenomics (NEO)?

Recent and active filers of NeoGenomics (NEO) disclosures include Gilbert Cisneros. The full member-by-member trade list is on this page.

Do Democrats or Republicans trade NeoGenomics (NEO) more?

Across disclosed NeoGenomics (NEO) trades, 71% were by Democrats and 29% by Republicans, led by Democrats (71%).

What is the most recent congressional NeoGenomics (NEO) trade?

The most recent disclosed NeoGenomics (NEO) filing reported a buy by Gilbert Cisneros, filed Sep 9, 2026.

What is NeoGenomics (NEO)'s Tide Score?

NeoGenomics (NEO) has a Quantellect Tide Score of 45 (Calm Tide). The Tide Score is a 0-100 read blending price forecast, smart-money flow, technicals, and social sentiment; higher is more bullish.

Browse all stocks Congress tradesCongressional trading overviewNeoGenomics (NEO) stock overview

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.